Genedx Holdings stocks are 8% higher today

Genetic inspection company’s stock GENEDX HOLDINGS (WGS 8.09%)) It was a pretty hot item for the second trading day of this week. After the company released a encouraging two -quarter earnings report, investors have earned more than 8% of their stocks. It looked especially good next to the 0.3% slump of the benchmark. S & P 500 index.

The highest growth rate of nearly 50%in 2Q

The import report, which was well released before the market opened, said GenedX booked almost $ 135 million in sales. This was 49% higher than the previous year, and sales of EXME and Genome testing were improved by 69%, a total of 23,102.

Image Source: Getty Image.

The better is that the company made a profit every year due to losses. Net profit, which is not a director, or a non -GAAP (adjustment), was less than $ 15 million during this period, compared to more than $ 2 million losses in the second quarter of 2024, Genedx earned $ 0.50 during that period.

The two headlines were much higher than the consensus analyst estimates. On average, experts who tracked the company’s stocks were only $ 88 million, and some of the changes in sales and the lighter adjustment net profit of $ 0.12 per share were much brighter.

Increased hope

Combining this solid growth rate, GENEDX has filed a specific guideline for the whole in 2025. The company now thinks that sales are now much higher than $ 360 million to $ 370 million from $ 400 million to $ 445 million. Most of these are expected to come from 48%to 52%compared to 2024 thanks to EXOME and Genome sales. Previously, the project was 30%.

GENEDX has not changed the adjustment net growth rate guidelines. The company is ambiguous about this, and the indicator predicts that the metrics of each quarter and the year will be amnified.